Active, Not Recruiting
Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer
NCT05481476
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +5 more
- Locations
-
- Cancer center of SunYat-sen University Guangzhou, Guangdong, China